Evidence map›Paper›PMID 34848758›Full record

ArticleScientific reports2021

A hydrated 2,3-diaminophenazinium chloride as a promising building block against SARS-CoV-2.

Rajani Kanta Mahato, Ayan Kumar Mahanty, Muddukrishnaiah Kotakonda, Sunnapu Prasad, Subires Bhattacharyya, Bhaskar Biswas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Journal of molecular structure · 2022
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rajani Kanta MahatoDepartment of Chemistry, University of North Bengal, Darjeeling, 734013, India.
Ayan Kumar MahantyDepartment of Biotechnology, University of North Bengal, Darjeeling, 734013, India.
Muddukrishnaiah KotakondaDepartment of Technology, Anna University, Chennai, 600025, India.
Sunnapu PrasadDepartment of Pharmaceutical Chemistry, Sri Ramakrishna Institute of Paramedical Science, Coimbatore, 641044, India.
Subires BhattacharyyaVice-Chancellor, University of North Bengal, Darjeeling, 734013, India. subires.bhattacharyya@gmail.com.
Bhaskar BiswasDepartment of Chemistry, University of North Bengal, Darjeeling, 734013, India. bhaskarbiswas@nbu.ac.in.
North Bengal University · INAnna University, Chennai · INSri Ramakrishna Institute of Paramedical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenazine scaffolds are the versatile secondary metabolites of bacterial origin. It functions in the biological control of plant pathogens and contributes to the producing strains ecological fitness and pathogenicity. In the light of the excellent therapeutic properties of phenazine, we have synthesized a hydrated 2,3-diaminophenazinium chloride (DAPH

Indexed as

Antiviral AgentsSARS-CoV-2Anti-Bacterial AgentsCoronavirus 3C ProteasesCOVID-19 Drug TreatmentCrystallography, X-RayEscherichia coliHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsMolecular Docking SimulationPhenazines3C-like proteinase, SARS-CoV-2Anti-Bacterial AgentsAntiviral AgentsCoronavirus 3C ProteasesPhenazines

Identifiers

PMID34848758
PMCPMC8633378
OpenAlexW3214912114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.